Free Testosterone

Two men can have identical total testosterone on a standard panel and feel completely different. One has energy, drive, and strength; the other is tired, low, and losing muscle.

The difference often comes down to how much of that testosterone is actually free to reach the tissues. This test measures that usable fraction directly, and it matters most when a routine number sits near the bottom of the range or when the proteins that carry testosterone are thrown off by age, weight, or illness.

What This Test Measures

Free testosterone (the unbound form of the main male sex hormone) is the small slice of testosterone circulating without clinging to carrier proteins. Most testosterone rides tightly bound to a protein called SHBG (sex hormone binding globulin) or loosely bound to albumin. Only the free fraction, plus some loosely held testosterone bound to albumin, is considered available to enter cells and act; the tightly SHBG-bound portion is generally regarded as unavailable, though the exact boundaries of this free hormone hypothesis are still debated.

This test uses a method called equilibrium dialysis, widely regarded as the most accurate way to measure the free fraction. It physically separates unbound testosterone from the protein-bound portion before measuring it, which sidesteps the errors of cheaper direct kits. In healthy men the free fraction is only a few percent of total testosterone; in women it averages around 1 percent of the total.

When a Normal Testosterone Number Can Mislead

SHBG is the wild card. When SHBG rises, more testosterone gets locked up, so your total number can look reassuring while the usable free portion runs low. When SHBG falls, the reverse happens and the free fraction can be higher than the total suggests.

This is why free testosterone earns its place mainly when total testosterone sits in the borderline zone or when something is shifting SHBG. Men with obesity, diabetes, thyroid disease, or advancing age are the classic cases. In one large study, men with low free testosterone but normal total testosterone carried the sexual and physical symptoms of deficiency, while men with low total but normal free testosterone tended to be heavier and lacked those symptoms.

Symptoms of Deficiency in Men

Low free testosterone tracks the felt symptoms of low testosterone more closely than the total number does. In men with type 2 diabetes, a calculated free testosterone estimate (a related but different measurement from the dialysis method used here) flagged every man who had both symptoms and biochemically low hormone, while total testosterone missed some of them.

A low reading points toward hypogonadism (the clinical term for testosterone deficiency), but it is not a standalone diagnosis. It needs to line up with real symptoms and be confirmed on a repeat test drawn in the morning.

Frailty and Muscle Loss in Kidney Disease

Men on hemodialysis are a group where low free testosterone carries clear weight. Over 12 months, men with roughly half the free testosterone of their peers had markedly higher odds of frailty, sarcopenia (age- or disease-related loss of muscle mass and strength), weaker grip, and slower walking.

Low free testosterone also predicted survival in dialysis cohorts, separating men who died from those who survived reasonably well in one analysis. These prognostic studies mostly used calculated free testosterone rather than the dialysis method this test uses, and the groups were small, so the association is suggestive rather than a fixed cutoff to act on.

Serious Illness and Survival

Low free testosterone shows up as a marker of worse prognosis across several severe illnesses, though whether it drives the outcome or simply reflects how sick someone is remains unsettled. In men with advanced liver disease awaiting transplant, low free testosterone was independently linked to about twice the risk of dying (adjusted hazard ratio 1.97). In men hospitalized with COVID-19 pneumonia, low levels tracked a steep rise in ICU transfer and death, though that study measured a calculated estimate rather than dialysis free testosterone.

High Levels in Women

For women, the concern usually runs the opposite direction. Elevated free testosterone is one of the clearest chemical signatures of polycystic ovary syndrome (PCOS), the most common hormonal disorder in women of reproductive age. In one study, free testosterone was raised in 61.0 percent of women with PCOS.

Because a woman's free testosterone is so low to begin with, it takes a sensitive method to measure it reliably, which is exactly where equilibrium dialysis or a well-validated calculation outperforms cheap direct kits. In a pooled analysis, a calculated free testosterone estimate caught about 89 out of 100 women with androgen excess and correctly cleared about 83 out of 100 without it.

Prostate Cancer in Men

In men, higher free testosterone has been linked to prostate cancer. Pooled and genetic (Mendelian randomization) analyses across international consortia point to higher free testosterone raising the risk of overall and aggressive prostate cancer, while low free testosterone was associated with lower risk in a collaborative analysis of 20 prospective studies.

This is where free testosterone stops behaving like a simple good-number, bad-number test. Lower levels look protective against prostate cancer yet mark worse survival in frail and seriously ill men; higher levels support strength and vitality yet may nudge prostate risk upward. Free testosterone is best read as an indicator of your overall androgen state, and which direction counts as concerning depends on the outcome and the person, not on chasing a single ideal figure.

Why One Reading Is Not Enough

Testosterone swings from morning to evening, day to day, and with illness, so a single value is a snapshot, not a trend. Free testosterone also carries real measurement variability: even careful equilibrium dialysis has some run-to-run imprecision, and reference ranges differ between labs because the assay is not fully standardized. Levels also decline gradually with age, so your own trajectory tells you more than any one number.

Get a baseline from a morning, fasting draw, then confirm anything abnormal with a repeat before drawing conclusions. If you are acting on a result, whether starting therapy, losing weight, or treating an underlying condition, retest at about 3 months to see the direction, then at least annually. Track it against the same lab and method whenever possible, since values are not interchangeable across assays.

When Results Can Be Misleading

• Time of day and fasting: testosterone peaks in the morning, so an afternoon or non-fasting draw can read falsely low and should not be treated as your true level.
• SHBG-shifting states: pregnancy, thyroid disease, obesity, and estrogen shifts change SHBG; a calculated free testosterone from immunoassay SHBG underestimates the true value in pregnancy, which is one reason direct dialysis measurement is preferred.
• Kidney disease and the assay: in people on hemodialysis, the altered blood chemistry lowers the accuracy of automated immunoassays, so a dialysis-based measurement is more trustworthy in this group.
• Testosterone therapy and estrogen: during testosterone treatment, small shifts in estradiol can change the free fraction even when SHBG holds steady, which can move the number without a matching change in symptoms.

What an Out-of-Pattern Result Should Prompt

A single odd number is a starting point, not a verdict. Pair free testosterone with total testosterone, SHBG, and albumin so the free fraction can be interpreted in context; without SHBG, a lone free testosterone value is hard to read.

If a man's free testosterone is low and symptoms fit, LH and FSH (pituitary hormones that drive the testes) help sort whether the problem is in the testes or the brain's signaling, and prolactin can flag a pituitary cause. Confirm on a repeat morning sample before any treatment, and involve an endocrinologist or urologist, especially before considering testosterone therapy, which is not appropriate for men seeking fertility or those with prostate cancer, a high red-blood-cell count, or recent heart events. For women with high free testosterone and irregular cycles or excess hair, the workup shifts toward PCOS and other androgen sources with a gynecologist or endocrinologist.